Amundi’s Chemed CHE Stock Holding History

Amundi’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Buy	53,856 +18,301	+51%	+$7.69M	0.01%	741
2026 Q1	$13.4M	Buy	35,555 +35,053	+6,983%	+$15M	﹤0.01%	833
2025 Q4	$215K	Sell	502 -27,145	-98%	-$11.8M	﹤0.01%	1741
2025 Q3	$12M	Buy	27,647 +19,602	+244%	+$8.88M	﹤0.01%	827
2025 Q2	$3.79M	Sell	8,045 -22,782	-74%	-$13M	﹤0.01%	973
2025 Q1	$19.1M	Sell	30,827 -6,963	-18%	-$3.96M	0.01%	716
2024 Q4	$20.1M	Sell	37,790 -11,340	-23%	-$6.39M	0.01%	716
2024 Q3	$28.9M	Sell	49,130 -17,230	-26%	-$9.77M	0.01%	648
2024 Q2	$35.8M	Buy	66,360 +62,155	+1,478%	+$35.6M	0.01%	599
2024 Q1	$2.51M	Buy	4,205 +189	+5%	+$115K	﹤0.01%	1104
2023 Q4	$2.31M	Sell	4,016 -796	-17%	-$445K	﹤0.01%	1157
2023 Q3	$2.42M	Buy	4,812 +1,849	+62%	+$961K	﹤0.01%	1128
2023 Q2	$1.6M	Sell	2,963 -5,934	-67%	-$3.24M	﹤0.01%	1206
2023 Q1	$4.89M	Buy	8,897 +1,151	+15%	+$587K	﹤0.01%	999
2022 Q4	$3.82M	Buy	7,746 +7,741	+154,820%	+$3.77M	﹤0.01%	1059
2022 Q3	$2K	Buy	+5	New	+$2.4K	﹤0.01%	1820
2021 Q3	–	Sell	-156	Closed	-$74K	–	1573
2021 Q2	$74K	Buy	+156	New	+$74.9K	﹤0.01%	1465

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Amundi's CHE Position: Q2 2026 in Review

Amundi increased its Chemed (CHE) stake by 51% in Q2 2026, buying an estimated $7.69M and bringing the position to 53,856 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #741.

Amundi first reported a position in CHE in Q2 2021 and has held it in 17 quarters since. The position peaked at $35.8M in Q2 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Amundi held 53,856 shares of Chemed worth $25.1M as of Q2 2026.
Amundi bought 18,301 Chemed shares in Q2 2026, an estimated $7.69M.
Chemed made up 0.01% of Amundi's portfolio in Q2 2026, its #741 holding.
Amundi first reported a position in Chemed in Q2 2021 and has held it in 17 quarters since.
Amundi's Chemed position peaked at $35.8M in Q2 2024.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.